GRI Bio Book Value Per Share Growth & History (GRI)
GRI Bio's book value per share was $12.07 for fiscal 2025.
View full GRI Bio company overviewGRI Bio annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $12.07 | -$202.77 | −94.38% |
| 2024 | 2024-12-31 | $214.85 | -$2,279.11 | −91.39% |
| 2023 | 2023-12-31 | $2,493.95 | $919,064.96 | — |
| 2022 | 2022-12-31 | -$916,571.01 | $11,129,904.24 | — |
| 2021 | 2021-12-31 | -$12,046,475.24 | -$6,584,147.97 | — |
| 2020 | 2020-12-31 | -$5,462,327.27 | — | — |
GRI Bio quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.70 | -$32.58 | −87.39% |
| Q1 2026 | 2026-03-31 | $6.65 | -$57.60 | −89.64% |
| Q4 2025 | 2025-12-31 | $12.07 | -$202.76 | −94.38% |
| Q3 2025 | 2025-09-30 | $17.08 | -$330.04 | −95.08% |
| Q2 2025 | 2025-06-30 | $37.28 | -$2,766.07 | −98.67% |
| Q1 2025 | 2025-03-31 | $64.25 | -$70,449.92 | −99.91% |
| Q4 2024 | 2024-12-31 | $214.83 | -$2,279.12 | −91.39% |
| Q3 2024 | 2024-09-30 | $347.12 | -$424,305.03 | −99.92% |
| Q2 2024 | 2024-06-30 | $2,803.35 | -$767,176.62 | −99.64% |
| Q1 2024 | 2024-03-31 | $70,514.17 | $4,122,158.11 | — |
| Q4 2023 | 2023-12-31 | $2,493.95 | $919,064.96 | — |
| Q3 2023 | 2023-09-30 | $424,652.15 | $8,010,985.78 | — |
| Q2 2023 | 2023-06-30 | $769,979.97 | $14,299,901.11 | — |
| Q1 2023 | 2023-03-31 | -$4,051,643.94 | $8,745,251.17 | — |
| Q4 2022 | 2022-12-31 | -$916,571.01 | $11,129,904.24 | — |
| Q3 2022 | 2022-09-30 | -$7,586,333.63 | -$29,276,449.63 | — |
| Q2 2022 | 2022-06-30 | -$13,529,921.14 | -$50,545,265.45 | — |
| Q1 2022 | 2022-03-31 | -$12,796,895.11 | -$42,681,993.66 | — |
| Q4 2021 | 2021-12-31 | -$12,046,475.24 | -$6,584,147.97 | — |
| Q3 2021 | 2021-09-30 | $21,690,116.01 | — | — |
| Q2 2021 | 2021-06-30 | $37,015,344.31 | — | — |
| Q1 2021 | 2021-03-31 | $29,885,098.55 | — | — |
| Q4 2020 | 2020-12-31 | -$5,462,327.27 | — | — |
GRI Bio book value per share trends
Over the last five fiscal years, GRI Bio's book value per share increased from -$5,462,327.27 to $12.07, a change of $5,462,339.34. The latest reported quarter, Q2 2026, shows $4.70.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review GRI Bio source filings ↗